USANA HEALTH SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
USANA HEALTH SCIENCES, INC. (USNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 47.50% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2017-03-01
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2015-04-04 was 40.40%, a 1.25% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2014-03-29 was 39.90%, a 8.70% decline year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2013-03-30 was 43.70%.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2016 was 47.50%, a 7.95% increase from fiscal 2016.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2016 was 44.00%, a 9.45% increase from fiscal 2015.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2015 was 40.20%, a 4.06% decline from fiscal 2013.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2013 was 41.90%, a 17.36% decline from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2016-12-31 | 47.50% 10-K · filed 2017-03-01 | |||
| 2016-01-02 | 44.00% 10-K · filed 2017-03-01 | |||
| 2015-10-03 | 43.60% 10-Q · filed 2015-11-12 | |||
| 2015-07-04 | 40.60% 10-Q · filed 2015-08-12 | |||
| 2015-04-04 | 40.40% 10-Q · filed 2015-05-13 | |||
| 2015-01-03 | 40.20% 10-K · filed 2017-03-01 | |||
| 2014-09-27 | 40.00% 10-Q · filed 2015-11-12 | |||
| 2014-06-28 | 39.90% 10-Q · filed 2015-08-12 | |||
| 2014-03-29 | 39.90% 10-Q · filed 2015-05-13 | |||
| 2013-12-28 | 41.90% 10-K · filed 2016-03-01 | |||
| 2013-09-28 | 42.50% 10-Q · filed 2014-11-06 | |||
| 2013-06-29 | 43.10% 10-Q · filed 2014-08-05 | |||
| 2013-03-30 | 43.70% 10-Q · filed 2014-05-07 | |||
| 2012-12-29 | 50.70% 10-K · filed 2015-03-17 | |||
| 2011-12-31 | 56.00% 10-K · filed 2014-03-13 | |||
| 2011-01-01 | 54.90% 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |